|
| Status |
Public on Feb 08, 2023 |
| Title |
BRD9 is essential for ribosome biogenesis and survival of multiple myeloma cells. |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
36780189 |
| NIH grant(s) |
| Grant ID |
Grant title |
Affiliation |
Name |
| P50 CA100707 |
SPORE in Multiple Myeloma |
DANA-FARBER CANCER INSTITUTE |
KENNETH C. ANDERSON |
|
| |
| Submission date |
Feb 26, 2022 |
| Last update date |
Aug 02, 2023 |
| Contact name |
Keiji Kurata |
| E-mail(s) |
Keiji_Kurata@DFCI.HARVARD.EDU
|
| Phone |
617-992-6981
|
| Organization name |
Dana-Farber Cancer Institute
|
| Street address |
450 Brookline Ave
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02215 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (54)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE197486 |
Chip-seq analysis after dBRD9-A treatment in human multiple myeloma cell line OPM2 |
| GSE197487 |
RNA-seq analysis after dBRD9-A treatment in human multiple myeloma cell line OPM2 and H929 |
|
| Relations |
| BioProject |
PRJNA810599 |
Less...
More...